nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.184	0.242	CbGbCtD
Letrozole—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.184	0.242	CbGbCtD
Letrozole—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.139	0.183	CbGbCtD
Letrozole—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0817	0.107	CbGbCtD
Letrozole—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0485	0.0637	CbGbCtD
Letrozole—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0327	0.043	CbGbCtD
Letrozole—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0312	0.0411	CbGbCtD
Letrozole—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0278	0.0366	CbGbCtD
Letrozole—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0163	0.0215	CbGbCtD
Letrozole—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0154	0.0203	CbGbCtD
Letrozole—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00205	0.065	CbGpPWpGaD
Letrozole—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00182	0.0575	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of steroid hormones and vitamin D—GC—chronic obstructive pulmonary disease	0.00165	0.0521	CbGpPWpGaD
Letrozole—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00148	0.047	CbGpPWpGaD
Letrozole—CYP2A6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00106	0.0336	CbGpPWpGaD
Letrozole—CYP2A6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000888	0.0281	CbGpPWpGaD
Letrozole—CYP2A6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000854	0.027	CbGpPWpGaD
Letrozole—CYP2A6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000771	0.0244	CbGpPWpGaD
Letrozole—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000754	0.0239	CbGpPWpGaD
Letrozole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—chronic obstructive pulmonary disease	0.000692	0.0219	CbGpPWpGaD
Letrozole—CYP2A6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000645	0.0204	CbGpPWpGaD
Letrozole—CYP2A6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00062	0.0196	CbGpPWpGaD
Letrozole—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000578	0.0183	CbGpPWpGaD
Letrozole—CYP19A1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000573	0.0181	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000474	0.015	CbGpPWpGaD
Letrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000463	0.0147	CbGpPWpGaD
Letrozole—CYP19A1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000457	0.0145	CbGpPWpGaD
Letrozole—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000448	0.0142	CbGpPWpGaD
Letrozole—CYP19A1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000416	0.0132	CbGpPWpGaD
Letrozole—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000389	0.0123	CbGpPWpGaD
Letrozole—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000375	0.0119	CbGpPWpGaD
Letrozole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000369	0.0117	CbGpPWpGaD
Letrozole—CYP2A6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000364	0.0115	CbGpPWpGaD
Letrozole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—chronic obstructive pulmonary disease	0.000361	0.0114	CbGpPWpGaD
Letrozole—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000354	0.0112	CbGpPWpGaD
Letrozole—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000343	0.00165	CcSEcCtD
Letrozole—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000343	0.00165	CcSEcCtD
Letrozole—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000342	0.00165	CcSEcCtD
Letrozole—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000342	0.00165	CcSEcCtD
Letrozole—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000342	0.00165	CcSEcCtD
Letrozole—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000342	0.00165	CcSEcCtD
Letrozole—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000342	0.00165	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000341	0.00164	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000341	0.00164	CcSEcCtD
Letrozole—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000339	0.00163	CcSEcCtD
Letrozole—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000339	0.00163	CcSEcCtD
Letrozole—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000339	0.0107	CbGpPWpGaD
Letrozole—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000337	0.00162	CcSEcCtD
Letrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000336	0.0107	CbGpPWpGaD
Letrozole—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000336	0.00162	CcSEcCtD
Letrozole—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000336	0.00162	CcSEcCtD
Letrozole—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000336	0.00162	CcSEcCtD
Letrozole—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000336	0.00162	CcSEcCtD
Letrozole—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000335	0.00161	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000334	0.00161	CcSEcCtD
Letrozole—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000334	0.00161	CcSEcCtD
Letrozole—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000333	0.0016	CcSEcCtD
Letrozole—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000332	0.0016	CcSEcCtD
Letrozole—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000332	0.0105	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.00033	0.0105	CbGpPWpGaD
Letrozole—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000329	0.00158	CcSEcCtD
Letrozole—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000329	0.00158	CcSEcCtD
Letrozole—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000329	0.00158	CcSEcCtD
Letrozole—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000329	0.00158	CcSEcCtD
Letrozole—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000329	0.00158	CcSEcCtD
Letrozole—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000327	0.00157	CcSEcCtD
Letrozole—Infection—Formoterol—chronic obstructive pulmonary disease	0.000327	0.00157	CcSEcCtD
Letrozole—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000325	0.0103	CbGpPWpGaD
Letrozole—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.00156	CcSEcCtD
Letrozole—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.00156	CcSEcCtD
Letrozole—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.00156	CcSEcCtD
Letrozole—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000324	0.00156	CcSEcCtD
Letrozole—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000323	0.00156	CcSEcCtD
Letrozole—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000323	0.00155	CcSEcCtD
Letrozole—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000323	0.00155	CcSEcCtD
Letrozole—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000322	0.00155	CcSEcCtD
Letrozole—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000322	0.00155	CcSEcCtD
Letrozole—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000322	0.00155	CcSEcCtD
Letrozole—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000321	0.00155	CcSEcCtD
Letrozole—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000321	0.00155	CcSEcCtD
Letrozole—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00032	0.00154	CcSEcCtD
Letrozole—Infection—Montelukast—chronic obstructive pulmonary disease	0.00032	0.00154	CcSEcCtD
Letrozole—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00032	0.00154	CcSEcCtD
Letrozole—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00032	0.00154	CcSEcCtD
Letrozole—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000317	0.00153	CcSEcCtD
Letrozole—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000316	0.00152	CcSEcCtD
Letrozole—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000313	0.00151	CcSEcCtD
Letrozole—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000313	0.00991	CbGpPWpGaD
Letrozole—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000311	0.0015	CcSEcCtD
Letrozole—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000311	0.0015	CcSEcCtD
Letrozole—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000309	0.00149	CcSEcCtD
Letrozole—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000306	0.00147	CcSEcCtD
Letrozole—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000305	0.00147	CcSEcCtD
Letrozole—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000305	0.00147	CcSEcCtD
Letrozole—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000305	0.00147	CcSEcCtD
Letrozole—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.00146	CcSEcCtD
Letrozole—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000302	0.00145	CcSEcCtD
Letrozole—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000301	0.00145	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.0003	0.00144	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.0003	0.00144	CcSEcCtD
Letrozole—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000299	0.00946	CbGpPWpGaD
Letrozole—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.00143	CcSEcCtD
Letrozole—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000298	0.00143	CcSEcCtD
Letrozole—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000296	0.00143	CcSEcCtD
Letrozole—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000296	0.00142	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000294	0.00141	CcSEcCtD
Letrozole—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000294	0.00141	CcSEcCtD
Letrozole—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.00141	CcSEcCtD
Letrozole—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000293	0.00141	CcSEcCtD
Letrozole—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000293	0.00141	CcSEcCtD
Letrozole—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000292	0.0014	CcSEcCtD
Letrozole—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00029	0.00139	CcSEcCtD
Letrozole—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00029	0.00139	CcSEcCtD
Letrozole—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00029	0.00139	CcSEcCtD
Letrozole—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000289	0.00139	CcSEcCtD
Letrozole—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000287	0.00138	CcSEcCtD
Letrozole—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000286	0.00138	CcSEcCtD
Letrozole—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000285	0.00137	CcSEcCtD
Letrozole—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000284	0.00137	CcSEcCtD
Letrozole—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000284	0.00137	CcSEcCtD
Letrozole—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000284	0.00137	CcSEcCtD
Letrozole—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000284	0.00137	CcSEcCtD
Letrozole—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000284	0.00137	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000283	0.00136	CcSEcCtD
Letrozole—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000283	0.00895	CbGpPWpGaD
Letrozole—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.00136	CcSEcCtD
Letrozole—Pain—Formoterol—chronic obstructive pulmonary disease	0.000282	0.00136	CcSEcCtD
Letrozole—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.00136	CcSEcCtD
Letrozole—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000282	0.00136	CcSEcCtD
Letrozole—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.00135	CcSEcCtD
Letrozole—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000281	0.00135	CcSEcCtD
Letrozole—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.00134	CcSEcCtD
Letrozole—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000278	0.00134	CcSEcCtD
Letrozole—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000278	0.00134	CcSEcCtD
Letrozole—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000277	0.00133	CcSEcCtD
Letrozole—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000276	0.00133	CcSEcCtD
Letrozole—Pain—Montelukast—chronic obstructive pulmonary disease	0.000276	0.00133	CcSEcCtD
Letrozole—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000276	0.00133	CcSEcCtD
Letrozole—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000275	0.00132	CcSEcCtD
Letrozole—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000274	0.00132	CcSEcCtD
Letrozole—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000274	0.00132	CcSEcCtD
Letrozole—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000273	0.00864	CbGpPWpGaD
Letrozole—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000273	0.00131	CcSEcCtD
Letrozole—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000272	0.00131	CcSEcCtD
Letrozole—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000271	0.00859	CbGpPWpGaD
Letrozole—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000271	0.00131	CcSEcCtD
Letrozole—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000271	0.00131	CcSEcCtD
Letrozole—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000271	0.0013	CcSEcCtD
Letrozole—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00027	0.0013	CcSEcCtD
Letrozole—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.00027	0.0013	CcSEcCtD
Letrozole—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00027	0.0013	CcSEcCtD
Letrozole—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000269	0.0013	CcSEcCtD
Letrozole—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000269	0.0013	CcSEcCtD
Letrozole—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000269	0.00129	CcSEcCtD
Letrozole—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000268	0.00129	CcSEcCtD
Letrozole—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000268	0.00129	CcSEcCtD
Letrozole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000268	0.00848	CbGpPWpGaD
Letrozole—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.00128	CcSEcCtD
Letrozole—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.00128	CcSEcCtD
Letrozole—CYP2A6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000264	0.00837	CbGpPWpGaD
Letrozole—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000264	0.00127	CcSEcCtD
Letrozole—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000262	0.00126	CcSEcCtD
Letrozole—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000262	0.00126	CcSEcCtD
Letrozole—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00026	0.00125	CcSEcCtD
Letrozole—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00026	0.00125	CcSEcCtD
Letrozole—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00026	0.00125	CcSEcCtD
Letrozole—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00026	0.00125	CcSEcCtD
Letrozole—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000259	0.00125	CcSEcCtD
Letrozole—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000257	0.00814	CbGpPWpGaD
Letrozole—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000257	0.00124	CcSEcCtD
Letrozole—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000257	0.00124	CcSEcCtD
Letrozole—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000257	0.00124	CcSEcCtD
Letrozole—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000256	0.00123	CcSEcCtD
Letrozole—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.00123	CcSEcCtD
Letrozole—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000256	0.00123	CcSEcCtD
Letrozole—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000255	0.00123	CcSEcCtD
Letrozole—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000255	0.00123	CcSEcCtD
Letrozole—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.00122	CcSEcCtD
Letrozole—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000252	0.00121	CcSEcCtD
Letrozole—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000252	0.00121	CcSEcCtD
Letrozole—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000251	0.00121	CcSEcCtD
Letrozole—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000247	0.00119	CcSEcCtD
Letrozole—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000246	0.00118	CcSEcCtD
Letrozole—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000246	0.00118	CcSEcCtD
Letrozole—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000242	0.00117	CcSEcCtD
Letrozole—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000242	0.00116	CcSEcCtD
Letrozole—CYP19A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00024	0.0076	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000237	0.00751	CbGpPWpGaD
Letrozole—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000236	0.00749	CbGpPWpGaD
Letrozole—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000236	0.00114	CcSEcCtD
Letrozole—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.00114	CcSEcCtD
Letrozole—CYP2A6—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000235	0.00745	CbGpPWpGaD
Letrozole—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000233	0.00112	CcSEcCtD
Letrozole—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000233	0.00112	CcSEcCtD
Letrozole—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000231	0.00111	CcSEcCtD
Letrozole—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000228	0.0011	CcSEcCtD
Letrozole—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000227	0.0072	CbGpPWpGaD
Letrozole—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000225	0.00108	CcSEcCtD
Letrozole—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000225	0.00108	CcSEcCtD
Letrozole—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.00107	CcSEcCtD
Letrozole—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000222	0.00107	CcSEcCtD
Letrozole—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000221	0.00106	CcSEcCtD
Letrozole—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00022	0.00106	CcSEcCtD
Letrozole—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000218	0.00105	CcSEcCtD
Letrozole—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000218	0.00105	CcSEcCtD
Letrozole—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000217	0.00687	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000215	0.00681	CbGpPWpGaD
Letrozole—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000213	0.00103	CcSEcCtD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000213	0.00674	CbGpPWpGaD
Letrozole—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.00102	CcSEcCtD
Letrozole—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000209	0.00101	CcSEcCtD
Letrozole—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000209	0.00101	CcSEcCtD
Letrozole—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000208	0.000999	CcSEcCtD
Letrozole—Rash—Formoterol—chronic obstructive pulmonary disease	0.000208	0.000999	CcSEcCtD
Letrozole—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000207	0.000998	CcSEcCtD
Letrozole—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000207	0.000998	CcSEcCtD
Letrozole—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000207	0.000998	CcSEcCtD
Letrozole—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000206	0.000993	CcSEcCtD
Letrozole—Headache—Formoterol—chronic obstructive pulmonary disease	0.000206	0.000993	CcSEcCtD
Letrozole—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000206	0.000992	CcSEcCtD
Letrozole—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.000991	CcSEcCtD
Letrozole—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000206	0.000989	CcSEcCtD
Letrozole—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000205	0.000987	CcSEcCtD
Letrozole—CYP2A6—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000204	0.00646	CbGpPWpGaD
Letrozole—Rash—Montelukast—chronic obstructive pulmonary disease	0.000203	0.000979	CcSEcCtD
Letrozole—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000203	0.000978	CcSEcCtD
Letrozole—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000203	0.000976	CcSEcCtD
Letrozole—Depression—Prednisone—chronic obstructive pulmonary disease	0.000203	0.000975	CcSEcCtD
Letrozole—Headache—Montelukast—chronic obstructive pulmonary disease	0.000202	0.000972	CcSEcCtD
Letrozole—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.0002	0.000964	CcSEcCtD
Letrozole—CYP2A6—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.0002	0.00633	CbGpPWpGaD
Letrozole—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.0002	0.000961	CcSEcCtD
Letrozole—CYP19A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000199	0.00631	CbGpPWpGaD
Letrozole—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000199	0.000958	CcSEcCtD
Letrozole—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.000951	CcSEcCtD
Letrozole—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000197	0.000948	CcSEcCtD
Letrozole—CYP19A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000197	0.00623	CbGpPWpGaD
Letrozole—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000196	0.000945	CcSEcCtD
Letrozole—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000196	0.000943	CcSEcCtD
Letrozole—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000196	0.000943	CcSEcCtD
Letrozole—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.000941	CcSEcCtD
Letrozole—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000196	0.000941	CcSEcCtD
Letrozole—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.000937	CcSEcCtD
Letrozole—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000192	0.000922	CcSEcCtD
Letrozole—CYP2A6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000191	0.00605	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000189	0.00598	CbGpPWpGaD
Letrozole—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.000908	CcSEcCtD
Letrozole—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.000889	CcSEcCtD
Letrozole—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.000884	CcSEcCtD
Letrozole—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000183	0.000882	CcSEcCtD
Letrozole—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000182	0.000878	CcSEcCtD
Letrozole—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000863	CcSEcCtD
Letrozole—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000178	0.000858	CcSEcCtD
Letrozole—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000178	0.000858	CcSEcCtD
Letrozole—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000174	0.000838	CcSEcCtD
Letrozole—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.00083	CcSEcCtD
Letrozole—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.00017	0.00082	CcSEcCtD
Letrozole—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000169	0.000815	CcSEcCtD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000169	0.00534	CbGpPWpGaD
Letrozole—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000167	0.00529	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000166	0.00527	CbGpPWpGaD
Letrozole—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000796	CcSEcCtD
Letrozole—CYP19A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000164	0.00519	CbGpPWpGaD
Letrozole—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.000776	CcSEcCtD
Letrozole—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000161	0.000776	CcSEcCtD
Letrozole—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00016	0.000771	CcSEcCtD
Letrozole—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.00016	0.000769	CcSEcCtD
Letrozole—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000159	0.000764	CcSEcCtD
Letrozole—CYP2A6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000159	0.00503	CbGpPWpGaD
Letrozole—CYP2A6—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000153	0.00484	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000153	0.00484	CbGpPWpGaD
Letrozole—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000152	0.000734	CcSEcCtD
Letrozole—CYP2A6—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000151	0.00478	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000151	0.00477	CbGpPWpGaD
Letrozole—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00015	0.00072	CcSEcCtD
Letrozole—CYP2A6—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000149	0.00471	CbGpPWpGaD
Letrozole—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000709	CcSEcCtD
Letrozole—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000147	0.000707	CcSEcCtD
Letrozole—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000698	CcSEcCtD
Letrozole—CYP19A1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000145	0.00459	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	0.000144	0.00457	CbGpPWpGaD
Letrozole—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000689	CcSEcCtD
Letrozole—CYP19A1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000143	0.00452	CbGpPWpGaD
Letrozole—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000686	CcSEcCtD
Letrozole—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.000682	CcSEcCtD
Letrozole—CYP2A6—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000139	0.00439	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000138	0.00438	CbGpPWpGaD
Letrozole—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00066	CcSEcCtD
Letrozole—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000651	CcSEcCtD
Letrozole—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000651	CcSEcCtD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000135	0.00428	CbGpPWpGaD
Letrozole—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000648	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000646	CcSEcCtD
Letrozole—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000643	CcSEcCtD
Letrozole—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000133	0.00422	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000132	0.00419	CbGpPWpGaD
Letrozole—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000624	CcSEcCtD
Letrozole—Oedema—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000624	CcSEcCtD
Letrozole—Infection—Prednisone—chronic obstructive pulmonary disease	0.000129	0.00062	CcSEcCtD
Letrozole—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000612	CcSEcCtD
Letrozole—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000609	CcSEcCtD
Letrozole—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000606	CcSEcCtD
Letrozole—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000603	CcSEcCtD
Letrozole—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000594	CcSEcCtD
Letrozole—CYP2A6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000122	0.00385	CbGpPWpGaD
Letrozole—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000121	0.00384	CbGpPWpGaD
Letrozole—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000568	CcSEcCtD
Letrozole—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.000567	CcSEcCtD
Letrozole—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000564	CcSEcCtD
Letrozole—CYP19A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000117	0.00369	CbGpPWpGaD
Letrozole—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00056	CcSEcCtD
Letrozole—CYP2A6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000115	0.00365	CbGpPWpGaD
Letrozole—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000549	CcSEcCtD
Letrozole—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000542	CcSEcCtD
Letrozole—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000541	CcSEcCtD
Letrozole—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000541	CcSEcCtD
Letrozole—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000538	CcSEcCtD
Letrozole—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000538	CcSEcCtD
Letrozole—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000533	CcSEcCtD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00011	0.00347	CbGpPWpGaD
Letrozole—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000514	CcSEcCtD
Letrozole—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000106	0.00051	CcSEcCtD
Letrozole—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.00051	CcSEcCtD
Letrozole—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000495	CcSEcCtD
Letrozole—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000493	CcSEcCtD
Letrozole—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000493	CcSEcCtD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.82e-05	0.00311	CbGpPWpGaD
Letrozole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.69e-05	0.00307	CbGpPWpGaD
Letrozole—Asthenia—Prednisone—chronic obstructive pulmonary disease	9.3e-05	0.000447	CcSEcCtD
Letrozole—CYP2A6—Metabolism—APIP—chronic obstructive pulmonary disease	9.28e-05	0.00294	CbGpPWpGaD
Letrozole—Pruritus—Prednisone—chronic obstructive pulmonary disease	9.17e-05	0.000441	CcSEcCtD
Letrozole—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	8.86e-05	0.000427	CcSEcCtD
Letrozole—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.57e-05	0.000412	CcSEcCtD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	8.31e-05	0.00263	CbGpPWpGaD
Letrozole—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.24e-05	0.000396	CcSEcCtD
Letrozole—Rash—Prednisone—chronic obstructive pulmonary disease	8.17e-05	0.000393	CcSEcCtD
Letrozole—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.16e-05	0.000393	CcSEcCtD
Letrozole—Headache—Prednisone—chronic obstructive pulmonary disease	8.12e-05	0.000391	CcSEcCtD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.96e-05	0.00252	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.72e-05	0.00244	CbGpPWpGaD
Letrozole—Nausea—Prednisone—chronic obstructive pulmonary disease	7.7e-05	0.00037	CcSEcCtD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	7.66e-05	0.00242	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	7.53e-05	0.00238	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GC—chronic obstructive pulmonary disease	7.51e-05	0.00238	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7e-05	0.00222	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.98e-05	0.00221	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.92e-05	0.00219	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	6.78e-05	0.00215	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.15e-05	0.00195	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GC—chronic obstructive pulmonary disease	5.98e-05	0.00189	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.82e-05	0.00184	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.74e-05	0.00182	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	5.69e-05	0.0018	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	5.65e-05	0.00179	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.56e-05	0.00176	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.56e-05	0.00176	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.85e-05	0.00154	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.79e-05	0.00152	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.46e-05	0.00141	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.4e-05	0.00139	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.23e-05	0.00134	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.17e-05	0.00132	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.1e-05	0.0013	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GCLC—chronic obstructive pulmonary disease	4.06e-05	0.00128	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.78e-05	0.0012	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.7e-05	0.00117	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.41e-05	0.00108	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.4e-05	0.00108	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.27e-05	0.00103	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	3.23e-05	0.00102	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.95e-05	0.000933	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.84e-05	0.0009	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.81e-05	0.000888	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.71e-05	0.000859	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.61e-05	0.000828	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.48e-05	0.000784	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.26e-05	0.000717	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.25e-05	0.000713	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.23e-05	0.000707	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.19e-05	0.000694	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.08e-05	0.000659	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.04e-05	0.000645	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.97e-05	0.000624	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ALB—chronic obstructive pulmonary disease	1.68e-05	0.000533	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.61e-05	0.00051	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	1.34e-05	0.000424	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.28e-05	0.000406	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.2e-05	0.000379	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.18e-05	0.000375	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.08e-05	0.000342	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.95e-06	0.000315	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.3e-06	0.000263	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.19e-06	0.000259	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.63e-06	0.000241	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.23e-06	0.000229	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	4.92e-06	0.000156	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.7e-06	0.000149	CbGpPWpGaD
